Ted Roberts, 68, is living his best life. He walks seven miles each morning near his home in St. Charles, Illinois; continues to work full time; and says he feels like he’s “40 again and my body is running on rocket fuel.”
It’s hard to believe that just seven months ago, Roberts contracted a near-fatal case of COVID-19, becoming the first patient with the disease to be admitted to Loyola University Medical Center, and the first patient at Loyola to receive the test drug remdesivir. During his hospitalization, Roberts, a Type 1 diabetic with broader autoimmune disease, spent nearly two weeks in the intensive care unit and 10 days on a ventilator.
It was on March 3, 2020, when Roberts, a retail consultant, was on a business trip in Maine where he believes he contracted the disease from a coworker. He says he began to feel sick later that same